KRAS and pancreatic adenocarcinoma: Among the 29 cancer types with KRAS mutations that were included in Table 1 of the study by Prior and colleagues, 43% of all KRAS mutations in human cancer are found in colorectal adenocarcinoma, followed by pancreatic adenocarcinoma (20%) and NSCLC adenocarcinoma subtype (14%).